Literature DB >> 26442850

Sarcoid-like reactions (SLRs) or autonomous sarcoidosis (AS)? Differentiation probably important?

Georgi Tchernev1, Anastasiya Atanasova Chokoeva2, Uwe Wollina3, Torello Lotti4,5.   

Abstract

Entities:  

Keywords:  Infection; Malignant; Sarcoid; Sarcoidosis; Treatment

Mesh：

Year:  2015        PMID： 26442850     DOI： 10.1007/s10354-015-0390-5

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN： 0043-5341


× No keyword cloud information.
  8 in total

Review 1.  Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases.

Authors:  Claire Immediato Daïen; Agnes Monnier; Pascal Claudepierre; Arnaud Constantin; Jean-Paul Eschard; Eric Houvenagel; Mahtab Samimi; Stephan Pavy; Edouard Pertuiset; Eric Toussirot; Bernard Combe; Jacques Morel
Journal:  Rheumatology (Oxford)       Date:  2009-05-07       Impact factor: 7.580

Review 2.  New treatment strategies for pulmonary sarcoidosis: antimetabolites, biological drugs, and other treatment approaches.

Authors:  Robert P Baughman; Jan C Grutters
Journal:  Lancet Respir Med       Date:  2015-07-20       Impact factor: 30.700

3.  Sarcoidosis exclusion criteria: the “simple truth” for a “complicated diagnosis”.

Authors:  G Tchernev; A A Chokoeva; C Schiavone; A M D Erme; C Tana; M Darling; J Kaley; S Gianfaldoni; U Wollina; T Lotti; J W Patterson
Journal:  J Biol Regul Homeost Agents       Date:  2015 Jan-Mar       Impact factor: 1.711

4.  Sarcoid type reaction: medical hypotheses.

Authors:  G Tchernev; A A Chokoeva; J W Patterson; U Wollina; T Lotti
Journal:  J Biol Regul Homeost Agents       Date:  2015 Jan-Mar       Impact factor: 1.711

5.  Effects of broad-spectrum antimycobacterial therapy on chronic pulmonary sarcoidosis.

Authors:  W P Drake; B W Richmond; K Oswald-Richter; C Yu; J M Isom; J A Worrell; G R Shipley
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2013-11-25       Impact factor: 0.670

6.  Oral antimycobacterial therapy in chronic cutaneous sarcoidosis: a randomized, single-masked, placebo-controlled study.

Authors:  Wonder P Drake; Kyra Oswald-Richter; Bradley W Richmond; Joan Isom; Victoria E Burke; Holly Algood; Nicole Braun; Thyneice Taylor; Kusum V Pandit; Caroline Aboud; Chang Yu; Naftali Kaminski; Alan S Boyd; Lloyd E King
Journal:  JAMA Dermatol       Date:  2013-09       Impact factor: 10.282

7.  Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis.

Authors:  Adriane D M Vorselaars; Anouk Verwoerd; Coline H M van Moorsel; Ruth G M Keijsers; Ger T Rijkers; Jan C Grutters
Journal:  Eur Respir J       Date:  2013-08-29       Impact factor: 16.671

Review 8.  The "mystery" of cutaneous sarcoidosis: facts and controversies.

Authors:  G Tchernev; J C Cardoso; A A Chokoeva; S B Verma; C Tana; J Ananiev; M Gulubova; S Philipov; N Kanazawa; P Nenoff; T Lotti; U Wollina
Journal:  Int J Immunopathol Pharmacol       Date:  2014 Jul-Sep       Impact factor: 3.219
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.